• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的临床特征可预测老年口腔鳞状细胞癌患者的生存情况。

A novel clinical signature predicts the survival of elderly patients with oral squamous cell carcinoma.

机构信息

Department of Oral and Maxillofacial and Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.

Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, National Clinical Research Center of Stomatology, Shanghai, 200011, People's Republic of China.

出版信息

Eur Arch Otorhinolaryngol. 2022 Jan;279(1):391-398. doi: 10.1007/s00405-021-06786-6. Epub 2021 Mar 30.

DOI:10.1007/s00405-021-06786-6
PMID:33783598
Abstract

BACKGROUND

The risk factors for the survival of elderly patients with oral squamous cell carcinoma (OSCC) are multifarious. Here, we developed a novel clinical signature to serve as an indicator of prognosis in these patients.

MATERIALS AND METHODS

Clinicopathological data were collected for 554 patients aged ≥ 60 years who were treated for primary OSCC. Overall survival (OS), disease-specific survival, and disease-free survival were the primary outcomes.

RESULTS

Multivariate cox regression analysis showed that high N stage, low hemoglobin level, low body mass index (BMI), and high neutrophil-to-lymphocyte ratio (NLR) showed a poor survival (P < 0.05). A nomogram was constructed with a c-index of 0.702.

CONCLUSION

A novel clinical signature including hemoglobin level, BMI, and NLR, which are obtained through noninvasive examinations can be used as prognostic indicators in clinical practice for elderly patients with OSCC.

摘要

背景

老年人口腔鳞状细胞癌(OSCC)患者的生存风险因素多种多样。在这里,我们开发了一种新的临床特征,作为这些患者预后的指标。

材料与方法

收集了 554 名年龄≥60 岁的原发性 OSCC 患者的临床病理数据。总生存期(OS)、疾病特异性生存期和无病生存期是主要观察终点。

结果

多变量 Cox 回归分析显示,N 分期高、血红蛋白水平低、体重指数(BMI)低和中性粒细胞与淋巴细胞比值(NLR)高均与较差的生存相关(P<0.05)。构建了一个包含血红蛋白水平、BMI 和 NLR 的列线图,其 C 指数为 0.702。

结论

一种新的临床特征,包括通过非侵入性检查获得的血红蛋白水平、BMI 和 NLR,可以作为老年 OSCC 患者临床实践中的预后指标。

相似文献

1
A novel clinical signature predicts the survival of elderly patients with oral squamous cell carcinoma.一种新的临床特征可预测老年口腔鳞状细胞癌患者的生存情况。
Eur Arch Otorhinolaryngol. 2022 Jan;279(1):391-398. doi: 10.1007/s00405-021-06786-6. Epub 2021 Mar 30.
2
A novel prognostic score based on systemic inflammatory biomarkers for patients with oral squamous cell carcinoma.一种基于系统性炎症生物标志物的口腔鳞状细胞癌患者新型预后评分。
Oral Dis. 2022 Apr;28(3):631-638. doi: 10.1111/odi.13774. Epub 2021 Jan 28.
3
Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma.肿瘤浸润免疫细胞在临床早期口腔鳞状细胞癌中的预后价值
J Oral Pathol Med. 2023 May;52(5):372-380. doi: 10.1111/jop.13357. Epub 2022 Oct 5.
4
[Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].外周血中性粒细胞与淋巴细胞比值:头颈部鳞状细胞癌患者的一种新型独立预后因素
Zhonghua Zhong Liu Za Zhi. 2017 Jan 23;39(1):29-32. doi: 10.3760/cma.j.issn.0253-3766.2017.01.006.
5
The systemic inflammation response index predicts the survival of patients with clinical T1-2N0 oral squamous cell carcinoma.系统炎症反应指数预测临床 T1-2N0 期口腔鳞状细胞癌患者的生存。
Oral Dis. 2022 Apr;28(3):600-610. doi: 10.1111/odi.13782. Epub 2021 Feb 9.
6
A novel T-cell proliferation-associated gene predicts prognosis and reveals immune infiltration in patients with oral squamous cell carcinoma.一个新型的 T 细胞增殖相关基因可预测口腔鳞状细胞癌患者的预后并揭示免疫浸润情况。
Arch Oral Biol. 2023 Aug;152:105719. doi: 10.1016/j.archoralbio.2023.105719. Epub 2023 May 9.
7
A novel pyroptosis-related signature predicts prognosis and indicates immunotherapy in oral squamous cell carcinoma.一种新型的 pyroptosis 相关特征可预测口腔鳞状细胞癌的预后并提示免疫治疗。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12057-12070. doi: 10.1007/s00432-023-05074-6. Epub 2023 Jul 8.
8
A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.基于四个低氧基因的口腔鳞状细胞癌预后标志物。
BMC Oral Health. 2021 May 3;21(1):232. doi: 10.1186/s12903-021-01587-z.
9
Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.铁死亡相关基因特征可预测口腔鳞状细胞癌患者的预后。
BMC Cancer. 2021 Jul 20;21(1):835. doi: 10.1186/s12885-021-08478-0.
10
Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.肿瘤浸润免疫细胞在口腔鳞状细胞癌中的预后意义
BMC Cancer. 2017 May 26;17(1):375. doi: 10.1186/s12885-017-3317-2.

引用本文的文献

1
Nomograms for predicting prognosis in postoperative lip squamous cell carcinoma patients.预测唇部鳞状细胞癌术后患者预后的列线图
Discov Oncol. 2025 Jun 4;16(1):1001. doi: 10.1007/s12672-025-02869-6.
2
Clinical and Therapeutic Considerations for Older Adults with Head and Neck Cancer.老年头颈部癌症患者的临床和治疗注意事项。
Clin Interv Aging. 2023 Mar 17;18:409-422. doi: 10.2147/CIA.S366155. eCollection 2023.
3
Management of Older Adults with Locally Advanced Head and Neck Cancer.局部晚期头颈癌老年患者的管理

本文引用的文献

1
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
2
Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.基于 CT 影像学、临床和血液学特征的综合列线图预测局部晚期非小细胞肺癌患者的生存情况。
Eur Radiol. 2019 Jun;29(6):2958-2967. doi: 10.1007/s00330-018-5949-2. Epub 2019 Jan 14.
3
Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study.
Cancers (Basel). 2022 Jun 5;14(11):2809. doi: 10.3390/cancers14112809.
4
Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy.老年患者头颈部鳞状细胞癌:放疗与化疗的作用
Cancers (Basel). 2022 Jan 18;14(3):472. doi: 10.3390/cancers14030472.
绝经后正常体重指数女性体脂与乳腺癌风险的关联:一项随机临床试验和观察性研究的二次分析。
JAMA Oncol. 2019 Feb 1;5(2):155-163. doi: 10.1001/jamaoncol.2018.5327.
4
Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer.性别、体重指数和初始病理诊断年龄对不同类型癌症的发病率和预后的影响。
Oncol Rep. 2018 Sep;40(3):1359-1369. doi: 10.3892/or.2018.6529. Epub 2018 Jun 27.
5
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project.个性化预测晚期结直肠癌患者生存:ARCAD 列线图项目。
J Natl Cancer Inst. 2018 Jun 1;110(6):638-648. doi: 10.1093/jnci/djx253.
6
Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics.使用蛋白质组学的呼出气体冷凝物生物标志物用于肺癌的早期诊断。
Am J Physiol Lung Cell Mol Physiol. 2017 Oct 1;313(4):L664-L676. doi: 10.1152/ajplung.00119.2017. Epub 2017 Jun 15.
7
Impact of body mass index on survival outcome in patients with differentiated thyroid cancer.体重指数对分化型甲状腺癌患者生存结局的影响。
Braz J Otorhinolaryngol. 2018 Mar-Apr;84(2):220-226. doi: 10.1016/j.bjorl.2017.02.002. Epub 2017 Feb 28.
8
Body mass index and prognosis in patients with head and neck cancer.体重指数与头颈癌患者的预后
Head Neck. 2017 Jun;39(6):1226-1233. doi: 10.1002/hed.24760. Epub 2017 Mar 21.
9
Preoperative Body Mass Index May Determine the Prognosis of Advanced Gastric Cancer.术前体重指数可能决定进展期胃癌的预后。
Nutr Cancer. 2016 Nov-Dec;68(8):1295-1300. doi: 10.1080/01635581.2016.1224363. Epub 2016 Oct 7.
10
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.